Metabolic syndrome and anticonvulsants: A comparative study of valproic acid and carbamazepine.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The aim of this study was to compare the risk of metabolic syndrome (MS) and evaluate related factors for MS among people with epilepsy treated with valproate (VPA) or carbamazepine (CBZ).

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Seizure

Title: Seizure

Publisher: Elsevier BV

ISSN (Electronic): 1532-2688

ISSN (Print): 1059-1311

Publication date (Electronic): May 2016

Volume: 38

Affiliations

[1 ] Department of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia; Neurology Clinic, Tartu University Hospital, Tartu, Estonia. Electronic address: aleksei.rakitin@kliinikum.ee.

[2 ] Department of Pathophysiology, University of Tartu, Tartu, Estonia; Centre of Translational Medicine, University of Tartu, Tartu, Estonia.

[3 ] Department of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia; Neurology Clinic, Tartu University Hospital, Tartu, Estonia.

Article

Publisher Item ID: S1059-1311(16)30001-2

DOI: 10.1016/j.seizure.2016.03.008

PubMed ID: 27061880

SO-VID: ae2a8e2c-249c-4978-bb92-f55917d458db

History

Keywords: Carbamazepine,Glucose,Insulin,Metabolic syndrome,Valproate,Valproic acid

Data availability:

Keywords: Carbamazepine, Glucose, Insulin, Metabolic syndrome, Valproate, Valproic acid

Metabolic syndrome and anticonvulsants: A comparative study of valproic acid and carbamazepine.

Read this article at

Abstract

Related collections

Karger: Nutrition and Dietetics

Author and article information

Journal

Affiliations

Article

History

Comments

Comment on this article

Cited by 8